Systems Biology in ELIXIR: modelling in the spotlight.

Biological data Biomolecular Models Biotechnology ELIXIR Communities FAIR Network Biology Systems Biology Systems Medicine

Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2022
Historique:
accepted: 24 10 2022
entrez: 6 2 2023
pubmed: 7 2 2023
medline: 8 2 2023
Statut: epublish

Résumé

In this white paper, we describe the founding of a new ELIXIR Community - the Systems Biology Community - and its proposed future contributions to both ELIXIR and the broader community of systems biologists in Europe and worldwide. The Community believes that the infrastructure aspects of systems biology - databases, (modelling) tools and standards development, as well as training and access to cloud infrastructure - are not only appropriate components of the ELIXIR infrastructure, but will prove key components of ELIXIR's future support of advanced biological applications and personalised medicine. By way of a series of meetings, the Community identified seven key areas for its future activities, reflecting both future needs and previous and current activities within ELIXIR Platforms and Communities. These are: overcoming barriers to the wider uptake of systems biology; linking new and existing data to systems biology models; interoperability of systems biology resources; further development and embedding of systems medicine; provisioning of modelling as a service; building and coordinating capacity building and training resources; and supporting industrial embedding of systems biology. A set of objectives for the Community has been identified under four main headline areas: Standardisation and Interoperability, Technology, Capacity Building and Training, and Industrial Embedding. These are grouped into short-term (3-year), mid-term (6-year) and long-term (10-year) objectives.

Identifiants

pubmed: 36742342
doi: 10.12688/f1000research.126734.1
pmc: PMC9871403
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright: © 2022 Martins dos Santos V et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

Mol Syst Biol. 2015 Dec 23;11(12):851
pubmed: 26700851
Nucleic Acids Res. 2020 Jan 8;48(D1):D445-D453
pubmed: 31586394
Bioinformatics. 2016 Feb 15;32(4):563-70
pubmed: 26490504
Nat Biotechnol. 2010 Dec;28(12):1248-50
pubmed: 21139605
Nucleic Acids Res. 2022 Jan 7;50(D1):D687-D692
pubmed: 34788843
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Sci Data. 2018 May 08;5:180029
pubmed: 29737976
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
FEBS J. 2022 Jan;289(1):90-101
pubmed: 33755310
Bioinformatics. 2016 Feb 15;32(4):638-40
pubmed: 26508761
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Science. 2009 Apr 3;324(5923):85-9
pubmed: 19342587
Nucleic Acids Res. 2019 Jan 8;47(D1):D1038-D1043
pubmed: 30445645
Methods Mol Biol. 2009;500:17-59
pubmed: 19399433
Pharm Res. 2005 Sep;22(9):1432-7
pubmed: 16132354
Nucleic Acids Res. 2021 Jan 8;49(D1):D570-D574
pubmed: 33156326
CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):71-72
pubmed: 28035755
Sci Signal. 2020 Mar 24;13(624):
pubmed: 32209698
Bioinformatics. 2017 May 15;33(10):1589-1590
pubmed: 28130238
Cell Death Differ. 2018 Nov;25(11):1952-1966
pubmed: 29500433
F1000Res. 2018 Jun 29;7:
pubmed: 30271575
Nucleic Acids Res. 2018 Jan 4;46(D1):D1266-D1270
pubmed: 29069414
Nucleic Acids Res. 2021 Jan 8;49(D1):D498-D508
pubmed: 33211880
Nucleic Acids Res. 2020 Jan 8;48(D1):D407-D415
pubmed: 31701150
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Trends Microbiol. 2019 Jun;27(6):524-537
pubmed: 30819548
BMC Syst Biol. 2015 Jul 11;9:33
pubmed: 26160520
J Pers Med. 2022 Jan 26;12(2):
pubmed: 35207655
Sci Signal. 2015 Dec 22;8(408):ra130
pubmed: 26696630
Nat Biotechnol. 2010 Sep;28(9):935-42
pubmed: 20829833
Nucleic Acids Res. 2019 Jan 8;47(D1):D711-D715
pubmed: 30357387
Bioinformatics. 2017 Aug 15;33(16):2580-2582
pubmed: 28379341
IEEE Trans Biomed Eng. 2016 Oct;63(10):2007-14
pubmed: 27305665
PLoS Comput Biol. 2021 Jan 28;17(1):e1007900
pubmed: 33507915
Nucleic Acids Res. 2021 Jan 8;49(D1):D516-D522
pubmed: 33174603
Nat Biotechnol. 2013 May;31(5):419-25
pubmed: 23455439
Nucleic Acids Res. 2018 Jan 4;46(D1):D656-D660
pubmed: 29092055
ACS Chem Neurosci. 2018 Jan 17;9(1):118-129
pubmed: 28950062
NPJ Syst Biol Appl. 2016 Sep 22;2:16020
pubmed: 28725475
Environ Res. 2020 Mar;182:108948
pubmed: 31841869
Big Data. 2016 Jun;4(2):97-108
pubmed: 27441714
Nucleic Acids Res. 2021 Jan 8;49(D1):D613-D621
pubmed: 33211851
Mol Syst Biol. 2021 Oct;17(10):e10387
pubmed: 34664389
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cell. 2018 Apr 5;173(2):283-285
pubmed: 29625045
J Pharm Sci. 1992 Jun;81(6):605-10
pubmed: 1355792
Curr Opin Syst Biol. 2017 Apr;2:67-73
pubmed: 28989987
J Integr Bioinform. 2020 Jun 29;17(2-3):
pubmed: 32598315
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954
pubmed: 27899562
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Bioinformatics. 2020 Nov 1;36(17):4649-4654
pubmed: 32573648
Bioinform Biol Insights. 2020 Jan 31;14:1177932219899051
pubmed: 32076369
Netw Syst Med. 2021 Feb 25;4(1):2-50
pubmed: 33659919
Mol Syst Biol. 2020 Feb;16(2):e8664
pubmed: 32073727
Mol Syst Biol. 2021 Feb;17(2):e9982
pubmed: 33620773
Cell Syst. 2018 Dec 26;7(6):567-579.e6
pubmed: 30503647
Pharmacol Ther. 2020 Aug;212:107555
pubmed: 32320730
Bioinformatics. 2017 Jul 15;33(14):i311-i318
pubmed: 28881985
Bioinformatics. 2020 May 1;36(10):3290-3291
pubmed: 32044952
NPJ Syst Biol Appl. 2018 Jun 2;4:21
pubmed: 29872544
J Integr Bioinform. 2020 Jun 29;17(2-3):
pubmed: 32598316
Interface Focus. 2016 Apr 6;6(2):20150103
pubmed: 27051515
BMC Bioinformatics. 2010 Jan 04;11:5
pubmed: 20047655
J Cheminform. 2017 Jun 6;9(1):33
pubmed: 29086040
Nucleic Acids Res. 2017 Jan 4;45(D1):D404-D407
pubmed: 27899646
Nucleic Acids Res. 2008 Jan;36(Database issue):D480-4
pubmed: 18077471
Nat Biotechnol. 2020 Mar;38(3):272-276
pubmed: 32123384
Front Bioeng Biotechnol. 2015 Feb 24;3:19
pubmed: 25759811
Nucleic Acids Res. 2016 Jan 4;44(D1):D38-47
pubmed: 26538599
Nucleic Acids Res. 2020 Jan 8;48(D1):D489-D497
pubmed: 31647099
Nucleic Acids Res. 2020 Jan 8;48(D1):D440-D444
pubmed: 31691833
Methods Mol Biol. 2019;2049:285-314
pubmed: 31602618

Auteurs

Vitor Martins Dos Santos (V)

Laboratory of Bioprocess Engineering, Wageningen University & Research, Wageningen, 6708 PB, The Netherlands.

Mihail Anton (M)

Department of Biology and Biological Engineering, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Chalmers University of Technology, Gothenburg, SE-41258, Sweden.

Barbara Szomolay (B)

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.

Marek Ostaszewski (M)

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, L-4367, Luxembourg.

Ilja Arts (I)

Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, 6200 MD, The Netherlands.

Rui Benfeitas (R)

National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Victoria Dominguez Del Angel (V)

Research and Platforms Department, Genopole, Evry-Courcouronnes, 91030, France.

Polonca Ferk (P)

Faculty of Medicine, Institute for Biostatistics and Medical Informatics, Centre ELIXIR-SI, University of Ljubljana, Ljubljana, SI-1000, Slovenia.

Dirk Fey (D)

Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, 4, Ireland.

Carole Goble (C)

Department of Computer Science, The University of Manchester, Manchester, M13 9PL, UK.

Martin Golebiewski (M)

Heidelberg Institute for Theoretical Studies - HITS, Heidelberg, 69118, Germany.

Kristina Gruden (K)

Department of Biotechnology and Systems Biology, National Institute of Biology, Ljubljana, SI-1000, Slovenia.

Katharina F Heil (KF)

ELIXIR Hub, Hinxton, Cambridge, CB10 1SD, UK.

Henning Hermjakob (H)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, CB10 1SD, UK.

Pascal Kahlem (P)

Scientific Network Management SL, Barcelona, 08015, Spain.

Maria I Klapa (MI)

Metabolic Engineering & Systems Biology Laboratory, Institute of Chemical Engineering Sciences, Foundation for Research & Technology - Hellas (FORTH/ICE-HT), Patras, 26504, Greece.

Jasper Koehorst (J)

Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, 6708WE, The Netherlands.

Alexey Kolodkin (A)

ISBE.NL, VU University of Amsterdam, Amsterdam, The Netherlands.
Competence Center for Methodology and Statistics; Transversal Translational Medicine, Translational Medicine Operations Hub, Luxembourg Institute of Health, Strassen, L-1445, Luxembourg.

Martina Kutmon (M)

Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, 6200 MD, The Netherlands.
Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, 6200 MD, The Netherlands.

Brane Leskošek (B)

Faculty of Medicine, Institute for Biostatistics and Medical Informatics, Centre ELIXIR-SI, University of Ljubljana, Ljubljana, SI-1000, Slovenia.

Sébastien Moretti (S)

SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Wolfgang Müller (W)

Heidelberg Institute for Theoretical Studies - HITS, Heidelberg, 69118, Germany.

Marco Pagni (M)

SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Tadeja Rezen (T)

Faculty of Medicine, University of Ljubljana, Ljubljana, SI-1000, Slovenia.

Miguel Rocha (M)

Centre of Biological Engineering, University of Minho, Braga, Portugal.

Damjana Rozman (D)

Faculty of Medicine, University of Ljubljana, Ljubljana, SI-1000, Slovenia.

David Šafránek (D)

Faculty of Informatics, Masaryk University, Brno, 602 00, Czech Republic.

Rahuman S Malik Sheriff (RSM)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, CB10 1SD, UK.

Maria Suarez Diez (M)

Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, 6708WE, The Netherlands.

Kristel Van Steen (K)

BIO3 - Systems Genetics, GIGA-R Medical Genomics, University of Liege, Liege, 4000, Belgium.
BIO3 - Laboratory for Systems Medicine, Department of Human Genetics, KU Leuven, Leuven, 3000, Belgium.

Hans V Westerhoff (HV)

ISBE.NL, VU University of Amsterdam, Amsterdam, The Netherlands.

Ulrike Wittig (U)

Heidelberg Institute for Theoretical Studies - HITS, Heidelberg, 69118, Germany.

Katherine Wolstencroft (K)

Leiden Institute of Advanced Computer Science, Leiden University, Leiden, 2333 CA, The Netherlands.

Anze Zupanic (A)

Department of Biotechnology and Systems Biology, National Institute of Biology, Ljubljana, SI-1000, Slovenia.

Chris T Evelo (CT)

Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, 6200 MD, The Netherlands.

John M Hancock (JM)

Faculty of Medicine, University of Ljubljana, Ljubljana, SI-1000, Slovenia.

Articles similaires

Glycogen Storage Disease Type II Humans Critical Pathways Europe
Humans Recurrence Male Female Middle Aged

Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system.

Thabata Martins Ferreira Campuzano, Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista et al.
1.00
Humans Female Uterine Cervical Neoplasms Brazil Middle Aged
Humans Female Breast Neoplasms Retrospective Studies Middle Aged

Classifications MeSH